ICM
DXPE icon

Invenomic Capital Management’s DXP Enterprises DXPE Stock Holding History

Invenomic Capital Management’s Portfolio DXPE Stock Details DXPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-45,749
Closed -$1.26M – 154
2022
Q4 		$1.26M Sell
45,749
-2,427
-5% -$64.5K 0.09% 129
2022
Q3 		$1.14M Buy
+48,176
New +$1.38M 0.1% 139

Other funds holding DXPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
MVP
Medina Value Partners Los Angeles, California $477M AUM 25.52% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Invenomic Capital Management's DXPE Position: Q1 2023 in Review

Invenomic Capital Management sold out of DXP Enterprises (DXPE) in Q1 2023, closing a stake of 45,749 shares — an estimated $1.26M sold.

Invenomic Capital Management first reported a position in DXPE in Q3 2022 and held it in 2 quarters. The position peaked at $1.26M in Q4 2022. 124 funds tracked by Wall St. Rank hold DXPE as of Q1 2023.

  • Invenomic Capital Management reported no remaining DXP Enterprises position as of Q1 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 45,749 DXP Enterprises shares in Q1 2023, an estimated $1.26M.
  • Invenomic Capital Management first reported a position in DXP Enterprises in Q3 2022 and held it in 2 quarters.
  • Invenomic Capital Management's DXP Enterprises position peaked at $1.26M in Q4 2022.
  • 124 funds tracked by Wall St. Rank held DXP Enterprises as of Q1 2023.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.